surmount-1 tirzepatide trial obesity without diabetes Presented at #ECO2025: In the SURMOUNT-5 phase 3b involving adults with type 2 diabetes, was superior to semaglutide in reducing body weight and waist circumference. Full trial results surmount-1 trial tirzepatide obesity without
Pay in 4 interest-free payments of $6.28 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 22 - Oct 27

























